Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T20:27:38.823Z Has data issue: false hasContentIssue false

Genes, suicide and decisions

Published online by Cambridge University Press:  16 April 2020

P. Courtet*
Affiliation:
University Montpellier I, 34000Montpellier, FranceDepartment of Psychological Medicine and Psychiatry, pôle urgences, Lapeyronie Hospital, CHU de Montpellier, 371, avenue du Doyen-G.-Giraud, 34295Montpellier cedex 5, FranceInserm U888, 34093Montpellier, France
S. Guillaume
Affiliation:
University Montpellier I, 34000Montpellier, FranceDepartment of Psychological Medicine and Psychiatry, pôle urgences, Lapeyronie Hospital, CHU de Montpellier, 371, avenue du Doyen-G.-Giraud, 34295Montpellier cedex 5, FranceInserm U888, 34093Montpellier, France
A. Malafosse
Affiliation:
Inserm U888, 34093Montpellier, FranceDepartment of Psychiatry, University of Geneva, Geneva, SwitzerlandDepartment of Medical Genetics and Laboratories, University Hospital of Geneva, Geneva, Switzerland
F. Jollant
Affiliation:
University Montpellier I, 34000Montpellier, FranceDepartment of Psychological Medicine and Psychiatry, pôle urgences, Lapeyronie Hospital, CHU de Montpellier, 371, avenue du Doyen-G.-Giraud, 34295Montpellier cedex 5, FranceInserm U888, 34093Montpellier, France
*
*Corresponding author. Tel.: +33467338581; fax: +33467338988. E-mail address: p-courtet@chu-montpellier.fr (P. Courtet).
Get access

Abstract

Objective

A better understanding of the pathophysiology of suicidal behaviour (SB) may enable the discovery of more specific treatments and a better identification of vulnerable patients. The vulnerability to SB appears to be underlied by genetic factors coding for traits rendering the individual less able to cope with stressing situations, and more likely to be engaged in a suicidal process.

Method

During the recent years, neuroscientific studies begun to identify potential endophenotypes.

Results

We have shown that disadvantageous decision making (DM) was involved in the vulnerability to SB. DM impairment appears to be independent of comorbid psychiatric disorders, associated with emotional dysregulation (i.e. affective lability trait and skin conductance responses), and modulated by serotonergic genotypes associated with SB. In recent fMRI studies, the region that is likely involved in DM, is overactivited in response to angry faces, suggesting a higher sensitivity to specific negative social stimuli. Deficit in risk evaluation and excessive response to specific emotional stimuli may represent key processes in the vulnerability to SB.

Conclusions

These potential endophenotypes may represent future relevant markers of vulnerability for the identification of vulnerable patients, and relevant targets for the development of new treatments.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.